In a nutshell, biotechnology is one of the most attractive and important industries heading into the next century, and Amgen is at the head of its impressive class. The appeal of blockbuster drugs knows no borders. Dialysis patients in New Zealand and Russia are helped just as much by Amgen's products as those stateside. Biotechnology products are protected by patents. With no competition for a set period of time, firms are able to produce healthy cash cows.
Firms are now able to get products on the market faster.
Biotechnology is approaching its renaissance. Much of what we've seen thus far out of Amgen and its peers is only the tip of the proverbial iceberg. Amgen is simply without equal in the biotechnology industry. This is also an industry where size is a major advantage, and Amgen has size in spades. You see, monster Amgen is creating wealth with its products every single day, and the increasing cash flow that it generates makes the company that much more powerful.